Cancer Drug Approvals Highlight SPT Week in Review

5. FDA Greenlights Combination Treatment for Metastatic NSCLC with BRAF V600E Mutation

A next generation sequencing test to detect lung cancer mutation was also approved.

https://www.specialtypharmacytimes.com/news/fda-greenlights-combination-treatment-for-metastatic-nsclc-with-braf-v600e-mutation

4. Rituximab Plus Hyaluronidase Combination Approved to Treat Leukemia, Lymphomas

Subcutaneous administration of Rituxan Hycela shortens treatment length to only 5 to 7 minutes.

https://www.specialtypharmacytimes.com/news/rituximab-plus-hyaluronidase-combination-approved-to-treat-leukemia-lymphomas

3. Top 10 Rated Pharmaceutical Companies of 2017

Consumer opinions shape list of top rated pharmaceutical manufacturers based on products and services.

https://www.specialtypharmacytimes.com/news/top-10-rated-pharmaceutical-companies-of-2017

2. Two Investigational Drugs to Treat Psoriatic Arthritis on the Horizon

Tofacitinib and Guselkumab show promise in patients with PsA.

https://www.specialtypharmacytimes.com/news/two-investigational-drugs-to-treat-psoriatic-arthritis-on-the-horizon

1. Pharmacy Outlook for Independent Pharmacies & Collaborative Practice

Forward-thinking pharmacies can capitalize on the rise of value-based care.

https://www.specialtypharmacytimes.com/news/pharmacy-outlook-for-independent-pharmacies--collaborative-practice